Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 11, Number 10—October 2005

Research

Vancomycin and Home Health Care

Thomas G. Fraser*1, Valentina Stosor*, Qiong Wang†, Anne Allen‡, and Teresa R. Zembower*Comments to Author 
Author affiliations: *Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA; †University of Illinois at Chicago School of Public Health, Chicago, Illinois, USA; ‡Northwestern Memorial Hospital, Chicago, Illinois, USA

Main Article

Table 4

Infection diagnoses in patients referred for home infusions of vancomycin

Diagnosis* Use per guidelines, no. (%), N = 180 Use outside guidelines, no. (%), N = 116 p value†
Skin or soft tissue infection 89 (49.4) 51 (44.0) 0.356
Osteomyelitis or septic arthritis 30 (16.7) 25 (21.6) 0.294
Postoperative wound infection 38 (21.1) 19 (16.4) 0.310
Orthopedic device-related infection 5 (2.8) 7 (6.0) 0.227
Central nervous system infection‡ 3 (1.7) 6 (5.2) 0.161
Urinary tract infection 36 (20.0) 13 (11.2) 0.042
Pneumonia 9 (5.0) 1 (0.9) 0.095
Bloodstream infection 61 (33.9) 16 (13.8) <0.001
Vascular device infection 21 (11.7) 10 (8.6) 0.398
Infective endocarditis 8 (4.4) 5 (4.3) 0.956

*Some patients had >1 diagnosis.
†Values <0.05 were considered significant.
‡Includes shunt infections.

Main Article

1Current affiliation: Cleveland Clinic Foundation, Cleveland, Ohio, USA

TOP